CCK stimulation of GLP-1 neurons involves α1-adrenoceptor-mediated increase in glutamatergic synaptic inputs

Diabetes. 2011 Nov;60(11):2701-9. doi: 10.2337/db11-0489. Epub 2011 Sep 1.

Abstract

Objective: Glucagon-like peptide 1 (GLP-1) is involved in the central regulation of food intake. It is produced within the brain by preproglucagon (PPG) neurons, which are located primarily within the brain stem. These neurons project widely throughout the brain, including to the appetite centers in the hypothalamus, and are believed to convey signals related to satiety. Previous work demonstrated that they are directly activated by leptin and electrical activity of the afferent vagus. Another satiety hormone, cholecystokinin (CCK), has also been linked to activation of brain stem neurons, suggesting that it might act partially via centrally projecting neurons from the nucleus tractus solitarius (NTS). The aim of this study was to investigate the neuronal circuitry linking CCK to the population of NTS-PPG neurons.

Research design and methods: Transgenic mice expressing yellow fluorescent protein (Venus) under the control of the PPG promoter were used to identify PPG neurons in vitro and to record their electrical and pharmacological profile.

Results: PPG neurons in the NTS were excited by CCK and epinephrine, but not by the melanocortin receptor agonist melanotan II. Both CCK and epinephrine acted to increase glutamatergic transmission to the PPG neurons, and this involved activation of α(1)-adrenergic receptors. Inhibition of adrenergic signaling abolished the excitatory action of CCK.

Conclusions: CCK activates NTS-PPG cells by a circuit involving adrenergic and glutamatergic neurons. NTS-PPG neurons integrate a variety of peripheral signals that indicate both long-term energy balance and short-term nutritional and digestional status to produce an output signal to feeding and autonomic circuits.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Cholecystokinin / analogs & derivatives
  • Cholecystokinin / metabolism*
  • Epinephrine / metabolism
  • Excitatory Postsynaptic Potentials* / drug effects
  • Female
  • Genes, Reporter
  • Glucagon-Like Peptide 1 / genetics
  • Glucagon-Like Peptide 1 / metabolism*
  • In Vitro Techniques
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neurons / drug effects
  • Neurons / metabolism*
  • Neurotransmitter Agents / pharmacology
  • Proglucagon / genetics
  • Proglucagon / metabolism
  • Promoter Regions, Genetic
  • Protein Isoforms / agonists
  • Protein Isoforms / antagonists & inhibitors
  • Protein Isoforms / genetics
  • Protein Isoforms / metabolism
  • RNA, Messenger / metabolism
  • Receptors, Adrenergic, alpha-1 / chemistry
  • Receptors, Adrenergic, alpha-1 / metabolism*
  • Receptors, Cholecystokinin / agonists
  • Receptors, Cholecystokinin / antagonists & inhibitors
  • Receptors, Cholecystokinin / genetics
  • Receptors, Cholecystokinin / metabolism*
  • Receptors, Glutamate / chemistry
  • Receptors, Glutamate / metabolism*
  • Solitary Nucleus / cytology
  • Solitary Nucleus / metabolism

Substances

  • Neurotransmitter Agents
  • Protein Isoforms
  • RNA, Messenger
  • Receptors, Adrenergic, alpha-1
  • Receptors, Cholecystokinin
  • Receptors, Glutamate
  • Proglucagon
  • Glucagon-Like Peptide 1
  • Cholecystokinin
  • Epinephrine